Sam-A Pharm Co Ltd
KOSDAQ:009300
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
15 140
19 050
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| KR |
S
|
Sam-A Pharm Co Ltd
KOSDAQ:009300
|
93.9B KRW |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
522.8B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
273.7B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
207.6B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
219.4B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
275.5B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
145.2B USD |
Loading...
|
Market Distribution
| Min | -163 055.6% |
| 30th Percentile | -2.2% |
| Median | 2.7% |
| 70th Percentile | 6.8% |
| Max | 22 874.8% |
Other Profitability Ratios
Sam-A Pharm Co Ltd
Glance View
Sam-A Pharm.Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Wonju, Gangwon-Do. The company went IPO on 2000-07-19. Co., Ltd is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The firm's products include remedies for respiratory, antibiotics, dermatitis treatments, dyspeptic agents, cold remedies, antifebriles, antiphlogistics, analgesics, antihistamines, and remedies for the circulatory, gastrointestinal, urinary systems, cardiovascular and other general pharmaceuticals. The company also provides children nutrition products under the brand name of NOMA.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Sam-A Pharm Co Ltd is 15.9%, which is below its 3-year median of 23.6%.
Over the last 3 years, Sam-A Pharm Co Ltd’s Operating Margin has decreased from 22.7% to 15.9%. During this period, it reached a low of 15.9% on Oct 30, 2025 and a high of 27.2% on Jun 30, 2024.